经皮顺行股浅动脉入路可安全用于下肢肢体缺血治疗手术
该单中心回顾性研究分析了2018至2020年间45例经皮顺行股浅动脉入路的下肢动脉闭塞性病变腔内治疗病例,结果显示即使使用较大鞘管,入路部位并发症为零,闭合装置使用安全。
要点
- 45例患者中80.0%接受多平面干预,最大鞘管尺寸以6F最常见(46.7%)。
- 闭合装置用于75.6%的病例,无闭合装置失败,全队列无入路部位并发症。
- 作者认为顺行股浅动脉入路可有效用于复杂腔内干预,即使鞘管尺寸较大。
核心结论
- 经皮顺行股浅动脉入路可有效用于下肢闭塞性疾病的复杂腔内干预,即使使用较大鞘管尺寸。
- 常规使用闭合装置是安全的,可提高患者舒适度并加快下床活动时间。
研究设计与样本
- 单中心回顾性综述,纳入2018年至2020年间在某大型学术机构因动脉闭塞性疾病接受经皮腹股沟下腔内干预的顺行经皮股浅动脉入路病例。
- 共纳入45例患者,平均体重指数25.25。
主要发现
- 干预指征包括组织缺损(64.4%)、静息痛(6.7%)、跛行(13.3%)和急性肢体缺血(11.1%)。
- 80.0%的患者接受多平面干预;血管成形术占68.8%,支架置入占8.3%,斑块旋切术占15.6%,血栓清除术占7.3%。
- 近四分之一病例涉及同期足部入路。
- 最大鞘管尺寸:4F占4.4%,5F占28.9%,6F占46.7%,7F占11.1%,8F占8.9%。
- 闭合装置用于75.6%的病例,无闭合装置失败;全队列无入路部位并发症。
临床怎么用
- 作者认为经皮顺行股浅动脉入路可有效用于下肢闭塞性疾病的复杂腔内干预,即使鞘管尺寸较大。
- 作者认为常规使用闭合装置是安全的,可提高患者舒适度并加快下床活动时间。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent studies have shown that antegrade access for treatment of infrainguinal peripheral vascular disease is associated with decreased radiation exposure and contrast use without a significant increase in access complication, although data are limited on antegrade superficial femoral artery (SFA) access for larger sheath sizes. We aim to describe a single institution's contemporary experience with percutaneous antegrade SFA access. METHODS: A retrospective review of percutaneous, infrainguinal endovascular interventions for arterial occlusive disease at a major academic institution was conducted between 2018 and 2020. Antegrade, percutaneous, SFA access cases were included. Information on demographics, indication, sheath size, arteries treated, type of intervention, concurrent pedal access, closure devices, and complications was collected and analyzed. RESULTS: A total of 45 patients with an average body mass index of 25.25 were identified. Indications for intervention included tissue loss (64.4%), rest pain (6.7%), claudication (13.3%), and acute limb ischemia (11.1%). Of which, 80.0% of patients had multilevel interventions. Angioplasty was performed in 68.8% of patients, stenting in 8.3%, atherectomy in 15.6%, and thrombectomy in 7.3%. Nearly a quarter of cases involved concurrent pedal access. Maximum sheath size was 4F for 4.4% of patients, 5F for 28.9%, 6F for 46.7%, 7F for 11.1%, and 8F for 8.9%. The closure device was utilized in 75.6% of cases, with no closure device failures. In the entire cohort, there were no demonstrated access site complications. CONCLUSIONS: This study demonstrates percutaneous, antegrade SFA access for complex endovascular interventions for infrainguinal occlusive disease can be effectively utilized, even with larger sheath size. Moreover, routine use of closure devices is safe, improving patient comfort and expediting time to ambulation.
引用
- Gedney R, Villacreses CF, Wooster MD, et al. Percutaneous, Antegrade Access of the Superficial Femoral Artery can be Safely Used in Procedures for the Treatment of Lower Extremity Limb Ischemia. Ann Vasc Surg. 2022. PMID: 36481670. doi:10.1016/j.avsg.2022.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。